National Institute for Communicable Diseases

What National Institute for Communicable Diseases does

The National Institute for Communicable Diseases (NICD) is a South African government public health institute headquartered in Johannesburg and operating as a division of the National Health Laboratory Service (NHLS). Founded in 2002 with 101–250 employees, NICD functions as South Africa's primary national reference laboratory and centre for communicable disease surveillance, reference diagnostics, outbreak response, and applied research. It serves the National Department of Health, the World Health Organization (including as a Regional Reference Laboratory, National Influenza Centre, and WHO Collaborating Centre for AMR in the AFRO region), and partner reference laboratories across southern Africa.

NICD operates a portfolio of interconnected digital surveillance and diagnostic products. Core technology assets include whole-genome sequencing and pathogen surveillance capabilities (SARS-CoV-2, influenza, RSV, bacterial meningitis pathogens), the National Notifiable Medical Conditions (NMC) Reporting System accessible via web portal and mobile applications on Android, Apple, and Huawei, the CoughWatchSA digital participatory surveillance platform for community self-reporting of respiratory symptoms, the GERMS-SA national laboratory surveillance network, and disease-specific interactive dashboards for TB, mpox, COVID-19, and respiratory pathogens. Supporting infrastructure includes BSL-3/BSL-4 high-containment laboratories and the Public Health Surveillance Bulletin publication. NICD leads the Network for Genomics Surveillance in South Africa (NGS-SA), a consortium of 8+ partner universities and the NHLS.

The institute is fully government-funded through the National Health Laboratory Service and South Africa's national health budget; it has no commercial revenue model, no pricing structure, and no external investors. Services are delivered through South Africa's public health infrastructure and via reference laboratory arrangements with WHO and regional partners. Operational scope is set by statutory mandate rather than market dynamics, and growth is bounded by public-sector budget cycles rather than competitive market forces.

Name

National Institute for Communicable Diseases

Legal name

National Institute for Communicable Diseases

Website

https://nicd.ac.za

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

101–250 employees

Short description

The National Institute for Communicable Diseases is South Africa's national public health reference institute, operating under the NHLS to provide communicable disease surveillance, reference diagnostics, outbreak response, and research for the National Department of Health, WHO, and regional partners.

Ownership category

akta.pro rank

Product category

Public Health Reference Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Public Administration (92)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

National Public Health Reference Laboratories (HLAJAIAA)

akta.pro secondary industries

Regional/State Public Health Laboratories (HLAJAIAB), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF), Public Health Laboratories & Diagnostic Oversight (BPAIAJAF)

Keywords

• Disease surveillance services
• Reference diagnostic laboratory
• Outbreak response coordination
• Public health research
• Genomic pathogen surveillance

Headquarters

HQ city

Johannesburg

HQ country

South Africa

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Distribution channels2 records

Marketing channels7 records

Core offering

NICD provides national reference diagnostic laboratory services, real-time communicable disease surveillance, outbreak response coordination, and applied public health research for South Africa. It operates as a division of the National Health Laboratory Service (NHLS), serving as the country's designated WHO regional reference laboratory for SARS-CoV-2 and pediatric bacterial meningitis, WHO National Influenza Centre, and WHO Collaborating Centre for Antimicrobial Resistance in the AFRO region. The institute delivers its services through dedicated disease centres, digital surveillance platforms, genomic sequencing networks, and a national sentinel laboratory surveillance system (GERMS-SA).

Product overview

The National Institute for Communicable Diseases (NICD) operates as South Africa's premier public health institute providing disease surveillance, diagnostic services, outbreak response, and research capabilities. The organization offers a portfolio of interconnected products including the NMC Reporting System for notifiable disease surveillance (accessible via web and mobile apps), disease-specific dashboards for real-time monitoring (TB Dashboard, Mpox Dashboard, Respiratory Pathogens Dashboard), participatory surveillance platforms like CoughWatchSA, and the GERMS-SA national laboratory surveillance network. These are complemented by weekly and monthly surveillance reports, genomic surveillance capabilities through NGS-SA, training services, proficiency testing schemes, and the Public Health Surveillance Bulletin publication. The product ecosystem enables South African health authorities to track, respond to, and research communicable diseases across the country.

Differentiator

Problem solved

Functional benefit

Brands

• GERMS-SA: A national laboratory surveillance network coordinated by NICD for diseases of public health importance.
• NMC Reporting
• CoughWatchSA
• Public Health Bulletin SA

Products and services

• NMC Reporting System National Notifiable Medical Conditions surveillance and reporting system for mandatory notification of communicable diseases, available via web portal and mobile applications for Android, Apple, and Huawei devices. Enables real-time reporting and epidemiological classification of disease outbreaks across South Africa.
• CoughWatchSA Digital participatory surveillance platform for influenza-like illnesses (ILI) in South Africa, enabling community members to self-report symptoms of acute respiratory infections through an online survey to address limitations in traditional respiratory disease surveillance.
• Interactive TB Dashboard Interactive dashboard tracking tuberculosis testing progress in South Africa toward a goal of testing five million people by 2025/26, developed with government, research, and laboratory agencies to monitor testing efforts and disparities across populations in real time.
• Disease-Specific Dashboards Interactive dashboards providing insights into the prevalence, trends, and surveillance of infectious diseases in South Africa, enabling users to track real-time data on specific diseases.
• GERMS-SA Surveillance Network National laboratory surveillance system coordinating national and sentinel laboratory-based and clinical surveillance programmes for diseases of public health importance in South Africa.
• Weekly Respiratory Pathogens Surveillance Report Weekly surveillance report tracking respiratory pathogens including SARS-CoV-2, influenza, RSV, and other respiratory disease trends in South Africa.
• SARS-CoV-2 Genomic Surveillance (NGS-SA) Genomic surveillance network monitoring SARS-CoV-2 variant evolution in South Africa through the Network for Genomics Surveillance in South Africa (NGS-SA), including KRISP, UCT, Stellenbosch, and other partner institutions.
• Mpox Updates Dashboard Live dashboard tracking mpox case statistics and outbreak updates in South Africa, integrated with Power BI visualization.
• Public Health Surveillance Bulletin Quarterly journal providing information on surveillance activities enabling effective monitoring of rates and distribution of diseases in South Africa.
• National Disease Surveillance Services Comprehensive national surveillance services across communicable diseases including respiratory infections, TB, HIV, STIs, malaria, AMR, enteric diseases, and zoonotic diseases, delivered through dedicated NICD centres and digital platforms.
• Reference Diagnostic Services Reference diagnostic laboratory services for rare, complex, and dangerous pathogens including respiratory pathogens (SARS-CoV-2, influenza, RSV, Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae) delivered through NICD's specialized centres and BSL-3/BSL-4 high-containment laboratories for the South African public health system and regional partners.
• Outbreak Response Services Coordination of national outbreak investigations and response for communicable diseases, including contact tracing across multiple countries under International Health Regulations, delivered in collaboration with the National Department of Health and international partners such as WHO and Pasteur Institute in Dakar.
• Proficiency Testing Schemes Laboratory proficiency testing schemes provided to laboratory clients to support quality assurance for diagnostic and antimicrobial susceptibility testing across South Africa and the region.
• Training and Capacity Building Services Training and capacity building services for healthcare workers, laboratory staff, and public health professionals in communicable disease surveillance, diagnostics, AMR, and outbreak response, delivered through NICD's centres.
• Public Health Research Services Applied public health research across communicable diseases, including epidemiology of respiratory infections, TB, HIV, AMR, mycoses, enteric and zoonotic diseases, delivered through NICD's dedicated centres and in collaboration with South African universities.

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core.

• National Health Laboratory Service (NHLS)coreStrategic or Co-development PartnerNICD operates as a division of the National Health Laboratory Service (NHLS), a statutory body providing laboratory services to the South African public health sector. The NICD website and systems (NMC Reporting, NMC app) are hosted on the nhls.ac.za domain, indicating deep operational integration. NICD provides specialized reference diagnostics, surveillance, and research capabilities that complement NHLS's broader laboratory service network.
• World Health Organization (WHO)coreStrategic or Co-development PartnerNICD serves as a WHO Collaborating Centre for Antimicrobial Resistance (AMR) in the AFRO region since 2017. The Centre for Respiratory Diseases and Meningitis serves as a WHO regional reference laboratory for pediatric invasive bacterial meningitis surveillance, a WHO regional reference laboratory for SARS-CoV-2, and a National Influenza Centre. NICD coordinates international outbreak responses under International Health Regulations, including contact tracing across multiple countries.
• Network for Genomics Surveillance in South Africa (NGS-SA)coreStrategic or Co-development PartnerNGS-SA is a multi-institution consortium led by NICD that includes KRISP at University of KwaZulu-Natal (UKZN), University of Cape Town (UCT), Stellenbosch University (SUN), University of the Free State (UFS), University of Pretoria, University of the Witwatersrand (WITS), and the NHLS. The network conducts ongoing genomic surveillance of SARS-CoV-2 and other pathogens, monitoring variant evolution and informing public health response.
• South African National Department of HealthcoreStrategic or Co-development PartnerNICD works closely with South Africa's Department of Health on outbreak investigations, surveillance, policy development, and public health response. NICD generates evidence to guide policy on respiratory disease control, TB management, HIV prevention, and vaccination. NICD supported the Department in developing the interactive TB dashboard and coordinates on national health campaigns.
• Vaccine Safety Net (VSN)coreStrategic or Co-development PartnerNICD is part of the WHO's Vaccine Safety Net, a global network of websites established by WHO that provides reliable information on vaccine safety. VSN members are located in countries around the world and provide scientifically based information on vaccine safety in various languages.
• WHO Collaborating Centre for AMR - AFRO RegioncoreStrategic or Co-development PartnerProf Olga Perovic leads the WHO Collaborating Centre for Antimicrobial Resistance in the AFRO region since 2017. The centre is responsible for national surveillance of antimicrobial resistance for nosocomial pathogens at GERMS-SA, laboratory quality for resistance and antimicrobial susceptibility testing methods, and training activities. This designation formalizes NICD's role in supporting WHO's global AMR surveillance goals.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Robert Koch Institute (RKI): Germany's federal public health institute responsible for disease surveillance, reference diagnostics, and applied research in infectious disease epidemiology; directly comparable in mandate (national reference lab, WHO collaborating centre functions, genomic surveillance) and in statutory relationship to a national health system.
• European Centre for Disease Prevention and Control (ECDC): EU agency operating EU-wide infectious disease surveillance, threat assessment, and reference laboratory coordination; comparable to NICD at a supranational level, particularly in the surveillance dashboard and epidemiological intelligence functions that mirror GERMS-SA and the NMC reporting system.
• National Institute of Infectious Diseases (NIID), Japan: Japan's national reference center for infectious diseases performing surveillance, reference diagnostics, and research; comparable in operating model as a government research institute with multiple specialized centres, BSL-equivalent containment, and WHO reference laboratory functions.
• U.S. Centers for Disease Control and Prevention (CDC): The largest national public health institute in the world; performs the same core functions as NICD (communicable disease surveillance, reference laboratory diagnostics, outbreak response, research) but at vastly greater scale and with a global footprint through its Global Health Center.
• National Institute for Public Health and the Environment (RIVM): Netherlands national public health institute performing infectious disease surveillance, reference diagnostics, and vaccine research; structurally similar to NICD as a government-funded national reference institute with WHO collaborating centre status and academic-affiliated researchers.
• UK Health Security Agency (UKHSA): UK government agency focused on health protection from infectious diseases and environmental hazards; comparable to NICD as a national reference laboratory network operating surveillance platforms, genomic sequencing capabilities, and outbreak response coordination under a public mandate.
• Public Health Agency of Canada (PHAC): Canadian national public health agency performing surveillance, reference laboratory diagnostics, outbreak response, and immunization programs; comparable to NICD in mandate and structure as a federally-funded agency coordinating disease-specific centres analogous to NICD's specialized centres (Respiratory, TB, HIV, AMR).

Direct peers

• Africa Centres for Disease Control and Prevention (Africa CDC): Continental public health agency coordinating infectious disease surveillance, outbreak response, and reference laboratory networks across African Union member states; NICD operates as a key implementing partner and WHO-designated reference laboratory within Africa CDC's framework, with overlapping mandates on AMR, genomic surveillance, and outbreak response.
• Pasteur Institute: French-founded international network of biomedical research institutes focused on infectious diseases; operates reference laboratory functions globally (including a Dakar institute that has partnered with NICD on hantavirus investigation), and competes with NICD for WHO reference designations and outbreak response mandates in francophone Africa.

Emerging players

• South African Medical Research Council (SAMRC): South Africa's national medical research council funding and conducting health research; overlaps with NICD's research mandate, shares the South African public funding ecosystem, and partners with NICD on surveillance-driven research, but is focused on extramural research funding rather than operating reference laboratories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/nicd_sa
• YouTubeyoutube.com/channel/UC5VEXHfh6kXP2d8EkFx16sw
• Facebookfacebook.com/100064952761277
• LinkedInlinkedin.com/company/national-institute-for-communicable-diseases-nicd
• Instagraminstagram.com/nicd_sa/?hl=en

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Institute for Communicable Diseases